ArticleProceedings of the National Academy of Sciences of the United States of America1998
Myeloid-specific transcriptional activation by murine myeloid zinc-finger protein 2.
Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 47 citations in OpenAlex.
- Tumor Necrosis Factor Receptors and C-C Chemokine Receptor-2 Positive Cells Play an Important Role in the Intraerythrocytic Death and Clearance ofPathogens (Basel, Switzerland) · 2024Article
- The tertiary structure of the human Xkr8-Basigin complex that scrambles phospholipids at plasma membranes.Nature structural & molecular biology · 2021Article
- Review
- Article
- Inherited IL-18BP deficiency in human fulminant viral hepatitis.The Journal of experimental medicine · 2019Article
- Article
- iPSC-derived cancer stem cells provide a model of tumor vasculature.American journal of cancer research · 2016Article
- Article
- Tim4- and MerTK-mediated engulfment of apoptotic cells by mouse resident peritoneal macrophages.Molecular and cellular biology · 2014Article
- Functional swapping between transmembrane proteins TMEM16A and TMEM16F.The Journal of biological chemistry · 2014Article
- Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members.The Journal of biological chemistry · 2013Article
- Structure of the SCAN domain from the tumor suppressor protein MZF1.Journal of molecular biology · 2006Article
- Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice.Genes and immunity · 2003Article
- Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.Proceedings of the National Academy of Sciences of the United States of America · 2001Article
- Mzf1 controls cell proliferation and tumorigenesis.Genes & development · 2001Article
- Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT.Nucleic acids research · 2000Article
- The zinc finger-associated SCAN box is a conserved oligomerization domain.Molecular and cellular biology · 1999Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myeloid zinc finger protein 2 (MZF-2) is a zinc-finger transcription factor that is expressed in myeloid cells, particularly in the cells committed to the neutrophilic lineage. Here we examine the ability of murine MZF-2 (mMZF-2) to activate transcription. The mMZF-2 protein binds to a DNA element (MZF-binding site) through its zinc-finger domain. When the intact mMZF-2 was cotransfected with a reporter gene, it did not activate transcription. However, N-terminal deletion mutants greatly enhanced transcription specifically in myeloid cells. Furthermore, in an in vivo competition assay, the middle region of MZF-2 inhibited the mMZF-2-mediated transcription activation. These results suggest that mMZF-2 is a transcriptional factor that can specifically work in myeloid cells and can be divided into at least three functional domains. The N-terminal domain inhibits transactivation by masking the effect of the activation domain. The middle region recruits a coactivator, which is responsible for myeloid-specific transcriptional activation. The C-terminal zinc-finger domain functions as a DNA-binding domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.